These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8115190)

  • 1. Malarial parasites and antioxidant nutrients.
    Levander OA; Ager AL
    Parasitology; 1993; 107 Suppl():S95-106. PubMed ID: 8115190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Qinghaosu, dietary vitamin E, selenium, and cod-liver oil: effect on the susceptibility of mice to the malarial parasite Plasmodium yoelii.
    Levander OA; Ager AL; Morris VC; May RG
    Am J Clin Nutr; 1989 Aug; 50(2):346-52. PubMed ID: 2756922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of antioxidants treatment on the pathogenesis of malarial infections: a review.
    Isah MB; Ibrahim MA
    Parasitol Res; 2014 Mar; 113(3):801-9. PubMed ID: 24525759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
    Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
    Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of the gametocytocidal/sporontocidal action of qinghaosu (artemisinin) by electron microscopy.
    Dutta GP; Mohan A; Tripathi R
    J Parasitol; 1990 Dec; 76(6):849-52. PubMed ID: 2254819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress in malaria parasite-infected erythrocytes: host-parasite interactions.
    Becker K; Tilley L; Vennerstrom JL; Roberts D; Rogerson S; Ginsburg H
    Int J Parasitol; 2004 Feb; 34(2):163-89. PubMed ID: 15037104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thalassaemia trait, red blood cell age and oxidant stress: effects on Plasmodium falciparum growth and sensitivity to artemisinin.
    Senok AC; Nelson EA; Li K; Oppenheimer SJ
    Trans R Soc Trop Med Hyg; 1997; 91(5):585-9. PubMed ID: 9463675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmodium vinckei petteri: identification of the stages sensitive to arteether.
    Caillard V; Beauté-Lafitte A; Chabaud AG; Landau I
    Exp Parasitol; 1992 Dec; 75(4):449-56. PubMed ID: 1493877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cysteamine broadly improves the anti-plasmodial activity of artemisinins against murine blood stage and cerebral malaria.
    Moradin N; Torre S; Gauthier S; Tam M; Hawari J; Vandercruyssen K; De Spiegeleer B; Fortin A; Stevenson MM; Gros P
    Malar J; 2016 May; 15(1):260. PubMed ID: 27150250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artemisinin, an endoperoxide antimalarial, disrupts the hemoglobin catabolism and heme detoxification systems in malarial parasite.
    Pandey AV; Tekwani BL; Singh RL; Chauhan VS
    J Biol Chem; 1999 Jul; 274(27):19383-8. PubMed ID: 10383451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Artemisinines--a new class of antimalarial preparations (a review of the literature)].
    Khomchenovskiĭ EI
    Med Parazitol (Mosk); 1986; (4):73-7. PubMed ID: 3531798
    [No Abstract]   [Full Text] [Related]  

  • 12. Selenium and sulfur in antioxidant protective systems: relationships with vitamin E and malaria.
    Levander OA
    Proc Soc Exp Biol Med; 1992 Jun; 200(2):255-9. PubMed ID: 1579591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between artemisinins and other antimalarial drugs in relation to the cofactor model--a unifying proposal for drug action.
    Haynes RK; Cheu KW; Chan HW; Wong HN; Li KY; Tang MM; Chen MJ; Guo ZF; Guo ZH; Sinniah K; Witte AB; Coghi P; Monti D
    ChemMedChem; 2012 Dec; 7(12):2204-26. PubMed ID: 23112085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic antimalarial activity of ketones with rufigallol and vitamin C.
    Mahajan SS; Kamath VR; Ghatpande SS
    Parasitology; 2005 Oct; 131(Pt 4):459-66. PubMed ID: 16174410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressive effects of the anti-oxidant N-acetylcysteine on the anti-malarial activity of artesunate.
    Arreesrisom P; Dondorp AM; Looareesuwan S; Udomsangpetch R
    Parasitol Int; 2007 Sep; 56(3):221-6. PubMed ID: 17544319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is haemozoin a target for antimalarial drugs?
    Meshnick SR
    Ann Trop Med Parasitol; 1996 Aug; 90(4):367-72. PubMed ID: 8944080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current progress in the chemistry, medicinal chemistry and drug design of artemisinin based antimalarials.
    Vroman JA; Alvim-Gaston M; Avery MA
    Curr Pharm Des; 1999 Feb; 5(2):101-38. PubMed ID: 10066886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development.
    Na-Bangchang K; Karbwang J
    Fundam Clin Pharmacol; 2009 Aug; 23(4):387-409. PubMed ID: 19709319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New trends in anti-malarial agents.
    Frédérich M; Dogné JM; Angenot L; De Mol P
    Curr Med Chem; 2002 Aug; 9(15):1435-56. PubMed ID: 12173975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UK malaria treatment guidelines.
    Lalloo DG; Shingadia D; Pasvol G; Chiodini PL; Whitty CJ; Beeching NJ; Hill DR; Warrell DA; Bannister BA;
    J Infect; 2007 Feb; 54(2):111-21. PubMed ID: 17215045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.